MEM 2026 Ideas

As painful as this is, I think we have to come to the realization that 2025 is not the year for SP growth. David has done a great job IMO and is moving the company forward. He has reduced staffing costs by over $100k per qtr and the progress has been 10 fold. Nobody could argue against this. So where does that leave MEM now? Well we aren't very financial so without some kind of support from large SH's or a partnership with Heranova or Brazilian investors then its another 2 CR's before we get our CE Mark. I an confident that if there is a possibility to help lessen the dilution David and his team will do whatever they can to prevent it. However, in saying that, I would also like to have seen David and Dr Lindley Edwards chip in and buy some shares to show some confidence in the company. Not sure how 2 of the main players in the BOD can expect the SP or SH be confident when they don't want to risk their $$ on this cheap (?) opportunity. Would love to hear from other holders their thoughts, but for me, 2025 was going to be our year, but like all good things in the small caps, delay and dilution gets us all. (mostly expected). For what its worth my thoughts on paper.

• CE Mark will be a 5 meter kick from directly in front. So the big question will then be, will clinics actually start to buy or use Felix? If we look at history then we can say it was just DCG and then Swim UP came along. How much of the market does swim up have? In my research I would say the following is a rough estimate. Rough Global data, DGC likely accounts for 60–70% of sperm separation procedures in ART due to its broader applicability, while swim-up accounts for 30–40%, particularly in normozoospermic cases or IUI. With 100% of clinicians saying they prefer Felix to DCG that does sound like a good possible addressable market.
• RoXsta. The last update I think was fantastic. It really sounds like a step that could lead to something else. I posted about the opportunities and we saw that in Singapore, they had a version of the RoXsta device available for people to see. Was this the "RoXsta™ Mega Cell diagnostic device" on the table next to the Felix we saw in the photo? No Idea, but if anyone has any information on this please share? As I mentioned also I am confused about this, as it sounds fantastic as I said and sounds like it could lead to revenue, but does this mean more testing and nothing to come from it for 12-18 months? Again no idea on this. I hope we can see research and diagnostic labs take this up early as regulations will be non-existent or low?
• Felix for animals. As some have mentioned why are they looking at other things when they need Felix to make money? I disagree with this in that we have to wait for CE Mark now, all the hard work has been done. Do we sit back now and wait for 9 months and see if that pays back SH value? I think we'd not be very happy to be paying all these people to sit on their hands while we wait. I think the equine study that is being does is being forgotten as a pretty good deal for us. Little $$ spent by MEM but testing by our partner is costing them time and money. This is a great outcome for MEM, maybe less $$ for us in the long term, but 'Beggars can't be choosers" when you are cash strapped. This actually could lead to funds before the CE Mark as it was announced that within the first 12 months we could see this. Well it's been 8 months since the study with Newcastle Uni and Equibreed UK Ltd was initiated. David has tried to keep timeframes so if he can, then between now and Oct we could see something for Non-Thoroughbred wise for horse breeders?

So if we can keep this thread free from spam, posting already known ann from the company for the sake of it, adding to those announcements with possibilities would be great. I hope HC will let us mod any posts that are off topic on this thread.